Remifentanil

Generic Name
Remifentanil
Brand Names
Ultiva
Drug Type
Small Molecule
Chemical Formula
C20H28N2O5
CAS Number
132875-61-7
Unique Ingredient Identifier
P10582JYYK
Background

Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.

Indication

For use during the induction and maintenance of general anesthesia.

Associated Conditions
-
Associated Therapies
Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation

Imaging Pain Relief in Osteoarthritis

First Posted Date
2014-08-05
Last Posted Date
2017-11-27
Lead Sponsor
University of Nottingham
Target Recruit Count
77
Registration Number
NCT02208778
Locations
🇬🇧

University of Nottingham - School of Medicine - Radiological Sciences, Nottingham, Nottinghamshire, United Kingdom

Remifentanil And Local Anesthesia Compared With Local Anesthesia For The Insertion Of Central Venous Catheters

Phase 4
Completed
Conditions
Interventions
First Posted Date
2014-08-01
Last Posted Date
2020-07-29
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
90
Registration Number
NCT02206022
Locations
🇫🇷

University Hospital of Toulouse, Toulouse, France

A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour

Phase 4
Completed
Conditions
Interventions
First Posted Date
2014-07-01
Last Posted Date
2018-10-15
Lead Sponsor
University of Birmingham
Target Recruit Count
401
Registration Number
NCT02179294
Locations
🇬🇧

Birmingham Clinical Trials Unit, Birmingham, West Midlands, United Kingdom

Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome

First Posted Date
2014-06-17
Last Posted Date
2023-09-21
Lead Sponsor
Albany Medical College
Target Recruit Count
93
Registration Number
NCT02164734
Locations
🇺🇸

Albany Medical Center, Albany, New York, United States

A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2014-04-14
Last Posted Date
2014-04-14
Lead Sponsor
Turkiye Yuksek Ihtisas Education and Research Hospital
Target Recruit Count
37
Registration Number
NCT02113150
Locations
🇹🇷

Aslı Demir, Ankara, Turkey

🇹🇷

Turkey Yuksek Ihtisas Education and Research Hospital, Ankara, Turkey

The Effect of Remifentanil Infusion During Emergence on the Incidence of Emergence Delirium

Not Applicable
Conditions
Interventions
First Posted Date
2014-04-09
Last Posted Date
2015-07-16
Lead Sponsor
Yeungnam University College of Medicine
Target Recruit Count
86
Registration Number
NCT02108795
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Yeungnam University hospital, Daegu, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath